| pubmed-article:14514588 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14514588 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:14514588 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
| pubmed-article:14514588 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:14514588 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:14514588 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:14514588 | lifeskim:mentions | umls-concept:C0443315 | lld:lifeskim |
| pubmed-article:14514588 | lifeskim:mentions | umls-concept:C0061355 | lld:lifeskim |
| pubmed-article:14514588 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:14514588 | lifeskim:mentions | umls-concept:C0549178 | lld:lifeskim |
| pubmed-article:14514588 | lifeskim:mentions | umls-concept:C1442461 | lld:lifeskim |
| pubmed-article:14514588 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:14514588 | pubmed:dateCreated | 2003-9-29 | lld:pubmed |
| pubmed-article:14514588 | pubmed:abstractText | Glucagon-like peptide 1 (GLP-1) is an insulinotropic gut hormone that, when given exogenously, may be a useful agent in the treatment of type 2 diabetes. We conducted a 3-month trial to determine the efficacy and safety of GLP-1 in elderly diabetic patients. | lld:pubmed |
| pubmed-article:14514588 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14514588 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14514588 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14514588 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14514588 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14514588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14514588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14514588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14514588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14514588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14514588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14514588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14514588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14514588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14514588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14514588 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14514588 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:14514588 | pubmed:issn | 0149-5992 | lld:pubmed |
| pubmed-article:14514588 | pubmed:author | pubmed-author:HabenerJoel... | lld:pubmed |
| pubmed-article:14514588 | pubmed:author | pubmed-author:ElahiDariushD | lld:pubmed |
| pubmed-article:14514588 | pubmed:author | pubmed-author:EganJosephine... | lld:pubmed |
| pubmed-article:14514588 | pubmed:author | pubmed-author:MeneillyGrayd... | lld:pubmed |
| pubmed-article:14514588 | pubmed:author | pubmed-author:GreigNigelN | lld:pubmed |
| pubmed-article:14514588 | pubmed:author | pubmed-author:TildesleyHugh... | lld:pubmed |
| pubmed-article:14514588 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14514588 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:14514588 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14514588 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14514588 | pubmed:pagination | 2835-41 | lld:pubmed |
| pubmed-article:14514588 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:meshHeading | pubmed-meshheading:14514588... | lld:pubmed |
| pubmed-article:14514588 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14514588 | pubmed:articleTitle | Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes. | lld:pubmed |
| pubmed-article:14514588 | pubmed:affiliation | Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. | lld:pubmed |
| pubmed-article:14514588 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14514588 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:14514588 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:14514588 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:14514588 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14514588 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14514588 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14514588 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14514588 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14514588 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14514588 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14514588 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14514588 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14514588 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14514588 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14514588 | lld:pubmed |
